AVI Products India Ltd
Incorporated in 1989, AVI Products India Ltd is in the business of trading of Dental Products and Equipment[1]
- Market Cap ₹ 18.2 Cr.
- Current Price ₹ 55.0
- High / Low ₹ 55.0 / 23.6
- Stock P/E
- Book Value ₹ 15.6
- Dividend Yield 0.00 %
- ROCE -20.6 %
- ROE -23.3 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Promoter holding has increased by 39.2% over last quarter.
Cons
- Stock is trading at 3.53 times its book value
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -13.2% over past five years.
- Company has a low return on equity of -5.84% over last 3 years.
- Company's cost of borrowing seems high
- Working capital days have increased from 637 days to 1,554 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Services Services Commercial Services & Supplies Trading & Distributors
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.79 | 1.78 | 2.07 | 3.60 | 3.43 | 4.10 | 2.38 | 3.34 | 3.61 | 4.85 | 4.70 | 1.17 | 0.60 | |
| 1.28 | 1.42 | 2.54 | 3.41 | 3.18 | 3.92 | 2.36 | 3.12 | 3.31 | 4.59 | 4.66 | 2.65 | 2.49 | |
| Operating Profit | 0.51 | 0.36 | -0.47 | 0.19 | 0.25 | 0.18 | 0.02 | 0.22 | 0.30 | 0.26 | 0.04 | -1.48 | -1.89 |
| OPM % | 28.49% | 20.22% | -22.71% | 5.28% | 7.29% | 4.39% | 0.84% | 6.59% | 8.31% | 5.36% | 0.85% | -126.50% | -315.00% |
| 0.04 | 0.09 | 0.13 | 0.00 | -0.04 | 0.06 | 0.15 | 0.03 | 0.08 | 0.21 | 0.24 | -0.30 | 0.25 | |
| Interest | 0.00 | 0.02 | 0.01 | 0.01 | 0.03 | 0.03 | 0.05 | 0.05 | 0.04 | 0.01 | 0.05 | 0.05 | 0.04 |
| Depreciation | 0.01 | 0.03 | 0.05 | 0.06 | 0.05 | 0.06 | 0.05 | 0.04 | 0.06 | 0.14 | 0.15 | 0.09 | 0.06 |
| Profit before tax | 0.54 | 0.40 | -0.40 | 0.12 | 0.13 | 0.15 | 0.07 | 0.16 | 0.28 | 0.32 | 0.08 | -1.92 | -1.74 |
| Tax % | 31.48% | 32.50% | 0.00% | 8.33% | 15.38% | 13.33% | 14.29% | 25.00% | 25.00% | 21.88% | 25.00% | 1.04% | |
| 0.38 | 0.27 | -0.40 | 0.11 | 0.10 | 0.12 | 0.06 | 0.12 | 0.21 | 0.26 | 0.05 | -1.94 | -1.74 | |
| EPS in Rs | 1.09 | 2.59 | -3.83 | 1.05 | 0.96 | 1.15 | 0.57 | 0.46 | 0.81 | 0.79 | 0.15 | -5.87 | -5.25 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -4% |
| 5 Years: | -13% |
| 3 Years: | -31% |
| TTM: | -86% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -335% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 7% |
| 3 Years: | 21% |
| 1 Year: | 73% |
| Return on Equity | |
|---|---|
| 10 Years: | -2% |
| 5 Years: | -3% |
| 3 Years: | -6% |
| Last Year: | -23% |
Balance Sheet
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1.04 | 1.04 | 1.04 | 1.04 | 1.04 | 1.04 | 1.04 | 2.58 | 2.58 | 3.31 | 3.31 | 3.31 |
| Reserves | 0.28 | 0.55 | 0.15 | 0.26 | 0.36 | 0.48 | 0.54 | 1.76 | 1.96 | 3.74 | 3.79 | 1.85 |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.33 | 0.20 | 0.52 | 0.02 | 0.01 | 0.26 | 0.82 | 0.01 | |
| 0.69 | 0.27 | 0.34 | 0.66 | 0.70 | 0.65 | 0.57 | 0.43 | 0.17 | 0.80 | 0.08 | 0.06 | |
| Total Liabilities | 2.01 | 1.86 | 1.53 | 1.96 | 2.43 | 2.37 | 2.67 | 4.79 | 4.72 | 8.11 | 8.00 | 5.23 |
| 0.08 | 0.17 | 0.42 | 0.37 | 0.33 | 0.31 | 0.37 | 0.45 | 0.58 | 1.44 | 1.36 | 0.15 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 1.93 | 1.69 | 1.11 | 1.59 | 2.10 | 2.06 | 2.30 | 4.34 | 4.14 | 6.67 | 6.64 | 5.08 | |
| Total Assets | 2.01 | 1.86 | 1.53 | 1.96 | 2.43 | 2.37 | 2.67 | 4.79 | 4.72 | 8.11 | 8.00 | 5.23 |
Cash Flows
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.07 | 0.32 | -0.04 | 0.05 | -0.28 | 0.31 | -0.15 | 0.10 | -0.62 | 0.31 | -0.77 | -3.11 | |
| 0.00 | -0.25 | -0.31 | 0.00 | -0.05 | -0.11 | -0.13 | -0.09 | -1.51 | -0.90 | 0.14 | 0.82 | |
| -0.08 | 0.00 | 0.00 | 0.00 | 0.31 | -0.15 | 0.26 | 2.09 | -0.06 | 2.48 | 0.50 | -0.86 | |
| Net Cash Flow | -0.02 | 0.06 | -0.34 | 0.04 | -0.02 | 0.05 | -0.01 | 2.10 | -2.18 | 1.90 | -0.14 | -3.16 |
| Free Cash Flow | 0.07 | 0.20 | -0.35 | 0.05 | -0.34 | 0.26 | -0.28 | -0.02 | -0.82 | -0.69 | -0.87 | -2.50 |
| CFO/OP | 65% | 89% | 9% | 26% | -112% | 172% | -700% | 27% | -173% | 146% | -1,925% | 209% |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 14.27 | 26.66 | 44.08 | 26.36 | 69.17 | 38.28 | 69.01 | 44.81 | 42.47 | 60.21 | 76.88 | 62.39 |
| Inventory Days | 121.67 | 100.86 | 140.20 | 127.75 | 202.38 | 144.70 | 351.40 | 276.41 | 282.96 | 251.80 | 241.37 | 284.15 |
| Days Payable | 97.33 | 57.63 | 58.01 | 66.92 | 66.86 | 37.80 | 40.81 | 26.58 | 13.39 | 71.61 | 5.89 | 9.24 |
| Cash Conversion Cycle | 38.61 | 69.88 | 126.27 | 87.19 | 204.69 | 145.17 | 379.60 | 294.64 | 312.03 | 240.40 | 312.37 | 337.30 |
| Working Capital Days | 173.32 | 155.84 | 96.98 | 53.74 | 122.38 | 74.78 | 156.43 | 177.04 | 250.75 | 165.57 | 191.82 | 1,553.59 |
| ROCE % | 47.79% | 28.87% | -28.06% | 10.44% | 13.86% | 10.43% | 7.33% | 6.50% | 7.18% | 5.56% | 1.97% | -20.63% |
Insights
In beta| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|
| E-commerce/Trading Segment Revenue Rs. thousands |
|
||||||||
| Food & Beverages Segment Revenue Rs. thousands |
|||||||||
| Number of Permanent Employees count |
|||||||||
| Purchases from Related Parties Rs. thousands |
|||||||||
| Sales to Related Parties Rs. thousands |
|||||||||
Extracted by Screener AI
Documents
Announcements
-
Closure of Trading Window
- Trading window closed from 1 October 2026 until 48 hours after Q2 FY2027 results.
- Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
-
Shareholder Meeting / Postal Ballot-Outcome of AGM
- 37th AGM on 24 Sep 2026 approved financials, auditors, re-designations, and asset sale to promoters/director.
- Shareholder Meeting / Postal Ballot-Outcome of AGM
- Reg. 34 (1) Annual Report.
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
-
Annual Report 2014
from bse
-
Annual Report 2013
from bse
-
Annual Report 2012
from bse
Business Overview:[1]
AVIPIL is engaged in a broad range of activities across India and globally, functioning as an advisor, consultant, planner, trainer, intermediary, broker, publisher, developer, agent, contractor, and service provider in the dental, medical, diagnostic, and healthcare
sectors.